Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
4.050
-0.220 (-5.15%)
At close: Aug 1, 2025, 4:00 PM
4.030
-0.020 (-0.49%)
After-hours: Aug 1, 2025, 4:45 PM EDT

Kezar Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
304969481822242
Upgrade
Market Cap Growth
-45.68%-28.81%-85.69%-41.42%240.23%214.65%
Upgrade
Enterprise Value
-71-82-13020470697
Upgrade
Last Close Price
4.056.729.4770.40167.2052.20
Upgrade
PS Ratio
--9.84---
Upgrade
PB Ratio
0.290.420.371.784.171.71
Upgrade
P/TBV Ratio
0.290.420.371.784.171.71
Upgrade
Debt / Equity Ratio
0.140.140.100.080.070.04
Upgrade
Asset Turnover
--0.03---
Upgrade
Quick Ratio
6.876.5311.4825.2225.3721.92
Upgrade
Current Ratio
7.096.7611.6625.9825.7722.48
Upgrade
Return on Equity (ROE)
-57.78%-55.00%-44.54%-29.24%-32.34%-38.12%
Upgrade
Return on Assets (ROA)
-32.00%-30.45%-25.26%-17.19%-18.48%-22.24%
Upgrade
Return on Capital (ROIC)
-34.08%-32.81%-26.43%-17.72%-19.12%-23.26%
Upgrade
Earnings Yield
-265.76%-170.78%-147.92%-14.18%-6.65%-17.28%
Upgrade
FCF Yield
-231.77%-151.42%-121.18%-12.55%-5.20%-15.38%
Upgrade
Buyback Yield / Dilution
-0.41%-0.48%-7.70%-27.69%-19.90%-130.58%
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q